Home
Home

vismodegib

9 Biotech Companies With FDA Approval Decision Dates In Q1 2012

9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha

Hungry biotechs make better partners for Big Pharma

Hungry biotechs make better partners for Big Pharma
Fierce Biotech

22 Hot Drugs Facing FDA Approval in 2012

22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com

Curis Earns $8 Million Milestone As NDA Accepted By FDA

Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha

FDA gives priority to Roche skin cancer drug vismodegib

FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK

Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study

Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg

Roche Seeks FDA Approval for Skin Cancer Drug

Roche Seeks FDA Approval for Skin Cancer Drug
Bloomberg

Roche preps vismodegib app after Ph2 skin cancer success

Roche preps vismodegib app after Ph2 skin cancer success
Fierce Biotech

10 promising late-stage cancer drugs

10 promising late-stage cancer drugs
Fierce Biotech

Roche, Curis Drug Prevented Lesions, Reduced Tumor Size in Trial

Roche, Curis Drug Prevented Lesions, Reduced Tumor Size in Trial
Bloomberg